#1 Clinical Trials Search in Europe

Flutamide

Flutamide, an anti-androgen medication, has been the subject of several clinical trials investigating its efficacy in treating various medical conditions. These trials explore the drug’s potential in addressing issues related to hormone-sensitive cancers, polycystic ovary syndrome (PCOS), premenstrual dysphoric disorder (PMDD), and acne vulgaris. The studies aim to evaluate Flutamide’s effectiveness, safety profile, and impact on patients’ quality of life across different dosages and administration methods.

Table of Contents

What is Flutamide?

Flutamide is a medication that belongs to a class of drugs known as anti-androgens. It is primarily used in the treatment of prostate cancer and other conditions affected by male hormones (androgens). Flutamide is also known by several other names, including Eulexin, Cytomid, Drogenil, and Flucinom[1]. These alternative names may be used in different countries or by different manufacturers, but they all refer to the same active ingredient.

How Flutamide Works

Flutamide works by blocking the effects of androgens, particularly testosterone, in the body. Androgens are hormones that play a crucial role in male characteristics and the growth of certain types of cancer, especially prostate cancer. By preventing these hormones from binding to their receptors, flutamide helps to slow down or stop the growth of cancer cells that depend on androgens to survive and multiply[2].

Conditions Treated with Flutamide

Flutamide is used to treat several conditions, including:

  • Prostate Cancer: This is the primary use of flutamide. It is often used in combination with other treatments, such as surgery or radiation therapy, to manage advanced prostate cancer[2].
  • Polycystic Ovary Syndrome (PCOS): Some studies have investigated the use of flutamide in women with PCOS, a condition characterized by hormonal imbalances that can cause irregular periods, excess hair growth, and fertility issues[3].
  • Acne Vulgaris: Research has explored the potential of topical flutamide in treating acne, particularly in cases where the condition is influenced by androgens[4].
  • Hirsutism: This condition, characterized by excessive hair growth in women, has been treated with flutamide in some cases due to its anti-androgenic properties[1].
  • Premenstrual Dysphoric Disorder (PMDD): Some studies have investigated the potential of flutamide in managing symptoms of PMDD, a severe form of premenstrual syndrome[5].

How Flutamide is Administered

The administration of flutamide can vary depending on the condition being treated and the specific treatment plan. Here are some common ways flutamide is used:

  • Oral tablets: For prostate cancer, flutamide is often taken as oral tablets, typically 250 mg three times a day[6].
  • Topical gel: In some experimental treatments for acne, flutamide has been formulated as a 1% topical gel applied directly to the skin[4].
  • Combination therapy: Flutamide is frequently used in combination with other treatments. For instance, in prostate cancer, it may be combined with drugs like leuprorelin, which suppress the production of testosterone[6].

Potential Side Effects

Like all medications, flutamide can cause side effects. Some potential side effects include:

  • Diarrhea
  • Nausea
  • Vomiting
  • Hot flashes
  • Decreased libido
  • Breast tenderness or enlargement in men
  • Liver function abnormalities (rare but serious)[3]

It’s important to note that not everyone experiences these side effects, and your doctor will monitor you closely during treatment to manage any that do occur.

Ongoing Research and Future Applications

Researchers continue to explore new potential uses for flutamide and ways to improve its effectiveness. Some areas of ongoing research include:

  • Intermittent therapy: Studies are investigating whether intermittent use of flutamide (alternating periods of treatment and no treatment) might be as effective as continuous use while reducing side effects in prostate cancer treatment[6].
  • Combination with immunotherapy: Research is exploring the potential of combining flutamide with immunotherapy drugs like pembrolizumab in treating certain types of head and neck cancers[7].
  • Topical applications: The development of topical flutamide formulations for conditions like acne could provide new treatment options with potentially fewer systemic side effects[4].
  • Hormonal disorders in women: Ongoing studies are investigating the potential benefits of flutamide in managing various hormonal disorders in women, including PCOS and PMDD[5].

As research continues, our understanding of flutamide’s potential uses and effects may expand, potentially leading to new treatment options for patients with various conditions affected by androgens.

Condition Flutamide Dosage Study Duration Key Outcomes Measured
Ovarian Cancer 125 mg daily 6 weeks Biomarker expression in ovarian tissue
Head and Neck Squamous Cell Carcinoma 250 mg, every 8 hours Not specified Progression-free survival, overall survival
Polycystic Ovary Syndrome (PCOS) 125 mg daily 6 months Lipid content in adipocytes, metabolic parameters
Premenstrual Dysphoric Disorder (PMDD) 125 mg twice daily 2 months Changes in premenstrual symptoms
Acne Vulgaris 1% topical gel, twice daily 8 weeks Changes in number of comedones, papules, and pustules
Prostate Cancer 50 mg (single dose) to 250 mg thrice daily Varied (1 day to 10 years) DNA double strand breaks, PSA levels, overall survival

FAQ

  • What is Flutamide and how does it work? Flutamide is an anti-androgen medication that blocks the action of testosterone and other androgens (male hormones) in the body. It works by binding to androgen receptors, preventing these hormones from affecting certain cells and tissues.
  • In which medical conditions is Flutamide being studied? Clinical trials are exploring Flutamide's potential in treating various conditions, including prostate cancer, ovarian cancer, polycystic ovary syndrome (PCOS), premenstrual dysphoric disorder (PMDD), head and neck squamous cell carcinoma, and acne vulgaris.
  • What are the common dosages of Flutamide used in these trials? The dosages vary depending on the condition being treated. For example, some trials use 125 mg daily for PCOS, while others use 250 mg twice daily for prostate cancer. Topical applications, such as 1% gel for acne, are also being studied.
  • Are there any potential side effects of Flutamide? Common side effects may include hot flashes, decreased libido, and breast tenderness. More serious side effects can include liver problems, which is why some trials closely monitor liver function. It's important to note that side effects can vary depending on the dosage and individual patient factors.
  • How long do these clinical trials typically last? The duration of clinical trials varies widely, ranging from a few weeks to several months or even years. For example, some PCOS studies last 6 months, while prostate cancer trials may follow patients for up to 10 years to assess long-term outcomes.

Ongoing Clinical Trials on Flutamide

  • Study on Enzalutamide and Drug Combination for High-Risk Localized Prostate Cancer Patients

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Ireland Spain

  • Study Comparing 177Lu-PSMA-617 with Standard Treatment for Men with Metastatic Hormone-Sensitive Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark France Germany +4

  • Study of enzalutamide compared to bicalutamide and flutamide in first-line treatment for patients with metastatic prostate cancer

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Ireland

Glossary

  • Androgen: A hormone that plays a role in male traits and reproductive activity. The most well-known androgen is testosterone.
  • Anti-androgen: A substance that blocks the effects of androgens in the body.
  • Polycystic Ovary Syndrome (PCOS): A hormonal disorder common among women of reproductive age, characterized by irregular periods, excess androgen levels, and polycystic ovaries.
  • Premenstrual Dysphoric Disorder (PMDD): A severe form of premenstrual syndrome (PMS) causing significant emotional and physical symptoms in the week or two before menstruation.
  • Biomarker: A measurable indicator of a biological state or condition, often used to assess the presence or progress of a disease or the effects of treatment.
  • Luteinizing Hormone (LH): A hormone produced by the pituitary gland that plays a crucial role in reproduction, ovulation, and testosterone production.
  • Follicle Stimulating Hormone (FSH): A hormone that stimulates the growth of ovarian follicles in women and sperm production in men.
  • Prostate-Specific Antigen (PSA): A protein produced by the prostate gland; elevated levels may indicate prostate cancer or other prostate conditions.
  • Brachytherapy: A type of radiation therapy where radioactive material is placed directly into or near a tumor.
  • Double Strand Breaks (DSBs): A type of DNA damage where both strands of the DNA double helix are severed.

References

  1. https://clinicaltrials.gov/study/NCT00699907
  2. https://clinicaltrials.gov/study/NCT00002881
  3. https://clinicaltrials.gov/study/NCT01889199
  4. https://clinicaltrials.gov/study/NCT05478330
  5. https://clinicaltrials.gov/study/NCT00611923
  6. https://clinicaltrials.gov/study/NCT00817739
  7. https://clinicaltrials.gov/study/NCT06694350